An introduction to the naturally occurring compounds found in cannabis and their scientific significance.
Cannabis is a chemically complex plant containing hundreds of naturally occurring compounds.
These include cannabinoids, terpenes, flavonoids and other substances that contribute to the plant's biological and chemical characteristics.
Researchers continue to investigate these compounds, their interactions and the factors influencing their composition.
Understanding cannabis chemistry provides a foundation for studying the plant's genetics, cultivation, pharmaceutical applications and scientific research.
The cannabis plant contains several important groups of chemical compounds.
These include:
Cannabinoids: A group of compounds associated with cannabis, including THC, CBD and numerous less extensively studied substances.
Terpenes: Aromatic compounds found in cannabis and many other plants.
Flavonoids: Plant compounds involved in pigmentation and other biological functions.
Other plant constituents: Including fatty acids, waxes, pigments and various naturally occurring substances.
The concentrations of these compounds can vary according to plant genetics, growing conditions, maturity, harvesting and processing.
Cannabinoids are among the most extensively studied compounds associated with cannabis.
The plant produces compounds known as phytocannabinoids.
More than 100 phytocannabinoids have been identified, although estimates vary as analytical methods and scientific classifications develop.
Cannabinoids are particularly associated with glandular trichomes, small structures found on the surfaces of cannabis flowers and certain other plant tissues.
The cannabinoid composition of a plant can vary substantially between cultivars and individual samples.
Delta-9-tetrahydrocannabinol, commonly known as THC, is one of the best-known cannabinoids.
In 1964, researchers Raphael Mechoulam and Yechiel Gaoni published landmark work identifying and characterising delta-9-THC.
THC is responsible for many of the characteristic intoxicating effects associated with cannabis.
It interacts with cannabinoid receptors in the body, particularly CB1 receptors associated with the nervous system.
THC can affect perception, memory, coordination, attention and other functions.
Research has also examined THC and THC-related pharmaceutical preparations in various clinical contexts.
However, potential therapeutic applications must be considered alongside adverse effects, clinical evidence and applicable regulatory requirements.
THC exposure can cause impairment, dizziness, anxiety and other unwanted effects.
Cannabidiol, commonly known as CBD, is another major phytocannabinoid.
CBD is generally described as non-intoxicating because it does not typically produce the characteristic intoxication associated with THC.
However, CBD is pharmacologically active and can affect biological processes.
Research has investigated CBD in a range of clinical settings.
Certain pharmaceutical CBD preparations have demonstrated efficacy in specific epilepsy syndromes and have received regulatory approval in some jurisdictions.
Evidence for many other proposed applications remains limited, mixed or insufficient.
CBD may also cause adverse effects and interact with other medicines.
It should not be assumed to be risk-free simply because it is plant-derived or non-intoxicating.
Beyond THC and CBD, researchers have identified numerous additional phytocannabinoids.
CBG is a naturally occurring cannabinoid associated with the biosynthetic pathways through which cannabis plants produce other cannabinoids.
Its chemical and biological properties are subjects of ongoing research.
CBN is associated with chemical changes involving THC, including oxidation and degradation processes.
Researchers are investigating its properties, but many commercial claims about CBN remain inadequately supported by clinical evidence.
CBC is another naturally occurring phytocannabinoid.
It has attracted scientific interest because of its chemical properties and potential biological activity.
Clinical evidence remains limited.
THCV is structurally related to THC but has a different chemical side chain.
Researchers are investigating how these structural differences influence its pharmacological behaviour.
Further research is required to establish its clinical significance.
An important aspect of cannabis chemistry is that many cannabinoids are initially produced by the plant in acidic forms.
Examples include:
Tetrahydrocannabinolic acid (THCA)
Cannabidiolic acid (CBDA)
Cannabigerolic acid (CBGA)
These compounds are chemically distinct from their corresponding neutral cannabinoids.
Decarboxylation is a chemical reaction involving the removal of a carboxyl group.
In cannabis, this process can convert cannabinoid acids into their corresponding neutral forms.
For example:
THCA → THC
CBDA → CBD
Heat and storage conditions can influence these transformations.
The degree of conversion depends on the compound and the conditions involved.
Understanding decarboxylation is important in cannabis analysis, processing and pharmaceutical manufacturing.
Terpenes are aromatic compounds found throughout the plant kingdom.
They contribute to the characteristic fragrances of citrus fruits, pine trees, herbs, flowers and many other botanical materials.
Cannabis produces a variety of terpenes, with concentrations influenced by genetics, cultivation and processing.
Commonly discussed cannabis terpenes include:
Myrcene is found in cannabis and other plants, including hops and mangoes.
It is commonly associated with earthy or herbal aromatic descriptions.
Limonene is widely found in citrus fruit peels and is associated with citrus-like aromas.
Pinene occurs in pine trees, rosemary and numerous other plants.
It contributes to pine-like aromatic characteristics.
Linalool is found in lavender and various aromatic plants.
It is associated with floral scent characteristics.
Beta-caryophyllene occurs in plants including black pepper and cloves.
It is of particular scientific interest because it can interact with cannabinoid CB2 receptors.
Researchers are investigating whether terpenes influence cannabinoid activity through pharmacological interactions.
Some laboratory findings suggest that particular plant compounds may interact with biological systems relevant to cannabinoid research.
However, findings from laboratory experiments do not necessarily establish clinically meaningful effects in humans.
The presence of a terpene in a cannabis product does not demonstrate that the product will produce a particular therapeutic outcome.
Further research is needed to understand the significance of potential cannabinoid–terpene interactions.
The term entourage effect is used to describe the hypothesis that multiple cannabis constituents may interact to produce effects that differ from those of individual compounds.
The concept is frequently discussed in relation to cannabinoids, terpenes and other plant constituents.
Although some experimental research has investigated interactions between cannabis compounds, strong clinical evidence supporting many broad entourage-effect claims remains limited.
The entourage effect should therefore be understood as an area of scientific investigation rather than a universally established explanation of cannabis effects.
Cannabis also contains flavonoids, a group of compounds widely distributed throughout the plant kingdom.
Flavonoids can contribute to plant pigmentation and participate in biological processes.
Certain flavonoids associated with cannabis have been investigated for their chemical and biological properties.
However, the presence of these compounds does not establish that cannabis products provide particular health benefits.
Their potential significance remains an area of ongoing research.
Cannabis composition is not determined by genetics alone.
Several factors can influence the chemical characteristics of harvested material.
Plant genetics
Different cultivars have varying capacities to produce cannabinoids and terpenes.
Cultivation environment
Light, temperature, humidity, nutrition and other conditions can influence plant development.
Plant maturity
Chemical composition may change during plant growth and flower development.
Harvesting and drying
Post-harvest practices can affect the stability and concentration of certain compounds.
Storage
Exposure to light, oxygen, temperature changes and time may influence chemical stability.
Laboratory analysis
Analytical methods and sampling practices are important when comparing chemical profiles.
These factors help explain why products sharing a cultivar name may have different chemical compositions.
For scientific research and pharmaceutical manufacturing, reliable chemical analysis is essential.
Laboratory testing can help identify and quantify cannabinoids and other relevant constituents.
Depending on the intended application and applicable requirements, testing may also address contaminants, product consistency and stability.
Accurate chemical characterisation supports research, manufacturing quality and regulatory compliance.
It is more informative than relying exclusively on informal strain names, aromas or visual appearance.
Cannabis contains a diverse collection of naturally occurring chemical compounds, including cannabinoids, terpenes and flavonoids.
THC and CBD are among the most extensively studied phytocannabinoids, while substances such as CBG, CBN, CBC and THCV continue to attract scientific interest.
Terpenes contribute to the plant's aromatic characteristics, and researchers are investigating possible interactions between different cannabis constituents.
However, many claims concerning these interactions remain scientifically uncertain.
Understanding cannabis composition requires careful attention to plant biology, chemical analysis and the distinction between preliminary research and established clinical evidence.
Educational disclaimer
This article is provided for general scientific and educational purposes only. It does not constitute medical advice, promote cannabis use or recommend any medicinal cannabis product. Scientific findings discussed here should not be interpreted as evidence that a particular cannabis preparation is safe or effective for treating a medical condition.